UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Equine veterinary journal, ISSN 0425-1644, 09/2019, Volume 51, Issue S53, pp. 21 - 21
Journal Article
American journal of respiratory and critical care medicine, ISSN 1073-449X, 10/2013, Volume 188, Issue 8, pp. 901 - 906
Methylxanthine | Histone deacetylase | Adenosine receptor | Phosphodiesterase | Respiratory System | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Science & Technology | Biological and medical sciences | Intensive care medicine | Medical sciences | Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy | Pneumology | Bronchodilator Agents - therapeutic use | Theophylline - administration & dosage | Theophylline - therapeutic use | Bronchodilator Agents - administration & dosage | Theophylline - pharmacokinetics | Bronchodilator Agents - pharmacokinetics | Humans | Theophylline - pharmacology | Bronchodilator Agents - pharmacology | Asthma - drug therapy | Pulmonary Disease, Chronic Obstructive - drug therapy | Index Medicus | Abridged Index Medicus
Journal Article
American journal of respiratory and critical care medicine, ISSN 1073-449X, 09/2016, Volume 194, Issue 5, pp. 559 - 567
Journal Article
Cochrane library, ISSN 1469-493X, 2011, Volume 2011, Issue 6, pp. CD003123 - CD003123
Epinephrine | Acute Disease | Lungs & airways | Bronchodilator Agents | Bronchiolitis | Randomized Controlled Trials as Topic | Infectious disease | Treatment | Child health | Respiratory infections | Bronchodilators | Respiratory infections: bronchitis & bronchiolitis | Respiratory infections: bronchiolitis | Albuterol | Medicine General & Introductory Medical Sciences | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Bronchodilator Agents - therapeutic use | Epinephrine - adverse effects | Epinephrine - therapeutic use | Bronchiolitis - drug therapy | Humans | Albuterol - therapeutic use | Infant | Bronchodilator Agents - adverse effects | Index Medicus
Journal Article
1987, Lung biology in health and disease, ISBN 9780824776336, Volume 31, xxii, 1158
Book
Respiratory medicine, ISSN 0954-6111, 2013, Volume 107, Issue 10, pp. 1538 - 1546
Pulmonary/Respiratory | Muscarinic antagonist | Long-acting bronchodilator | β-agonist | Randomised | Fixed-dose combination | COPD | Cardiac & Cardiovascular Systems | Respiratory System | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Bronchodilator Agents - therapeutic use | Bronchodilator Agents - administration & dosage | Forced Expiratory Volume - drug effects | Humans | Middle Aged | Benzyl Alcohols - administration & dosage | Benzyl Alcohols - adverse effects | Male | Pulmonary Disease, Chronic Obstructive - physiopathology | Benzyl Alcohols - therapeutic use | Quinuclidines - administration & dosage | Chlorobenzenes - administration & dosage | Vital Capacity - drug effects | Quinuclidines - therapeutic use | Female | Bronchodilator Agents - adverse effects | Drug Therapy, Combination | Quinuclidines - adverse effects | Severity of Illness Index | Double-Blind Method | Drug Administration Schedule | Treatment Outcome | Chlorobenzenes - adverse effects | Chlorobenzenes - therapeutic use | Quality of Life | Aged | Drug Combinations | Pulmonary Disease, Chronic Obstructive - drug therapy | Lung diseases, Obstructive | Confidence intervals | Smooth muscle | Chronic obstructive pulmonary disease | Drug therapy | Drug dosages | Index Medicus
Journal Article
1997, Lung biology in health and disease, ISBN 9780824794965, Volume 106, xvi, 443
Book
European journal of medicinal chemistry, ISSN 0223-5234, 05/2018, Volume 152, pp. 424 - 435
Journal Article
Cochrane library, ISSN 1469-493X, 2013, Volume 2013, Issue 12, pp. CD009019 - CD009019
Asthma (chronic): combination/additive drug treatment | Budesonide | Formoterol Fumarate | Lungs & airways | Asthma (chronic): bronchodilators | Anti‐Asthmatic Agents | Bronchodilator Agents | Ethanolamines | Asthma | Randomized Controlled Trials as Topic | Combination and additive therapies | Steroids, inhaled | Beta‐agonists, long‐acting | Asthma (chronic) | Child health | Bronchodilators | Asthma, chronic ‐ pharmacotherapy | Maintenance Chemotherapy | Medicine General & Introductory Medical Sciences | Drug Combinations | Nebulizers and Vaporizers | Combination/additive drug treatment | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Bronchodilator Agents - administration & dosage | Humans | Male | Asthma - drug therapy | Ethanolamines - administration & dosage | Maintenance Chemotherapy - methods | Adolescent | Adult | Female | Anti-Asthmatic Agents - administration & dosage | Budesonide - administration & dosage | Index Medicus | Medicin och hälsovetenskap
Journal Article
Journal of allergy and clinical immunology, ISSN 0091-6749, 2011, Volume 128, Issue 2, pp. 315 - 322
Allergy and Immunology | airway obstruction | agonist receptor | bronchodilators | Arginine/arginine genotype | muscarinic receptor | Allergy | Immunology | Life Sciences & Biomedicine | Science & Technology | Fundamental and applied biological sciences. Psychology | Fundamental immunology | Immunopathology | Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis | Biological and medical sciences | Medical sciences | Chronic obstructive pulmonary disease, asthma | Pneumology | Bronchodilator Agents - therapeutic use | Bronchodilator Agents - administration & dosage | Humans | Male | Arginine - genetics | Albuterol - administration & dosage | Scopolamine Derivatives - administration & dosage | Female | Bronchodilator Agents - adverse effects | Scopolamine Derivatives - therapeutic use | Scopolamine Derivatives - adverse effects | Tiotropium Bromide | Salmeterol Xinafoate | Asthma - physiopathology | Double-Blind Method | Receptors, Adrenergic, beta-2 - genetics | Administration, Inhalation | Albuterol - analogs & derivatives | Genotype | Treatment Outcome | Asthma - drug therapy | Asthma - genetics | Polymorphism, Single Nucleotide - genetics | Albuterol - therapeutic use | Respiratory Function Tests | Peak Expiratory Flow Rate | Albuterol - adverse effects | Antiasthmatic agents | Corticosteroids | Asthma | Studies | Chronic obstructive pulmonary disease | Drug therapy | Drug dosages | Index Medicus | Abridged Index Medicus
Journal Article
Chest, ISSN 0012-3692, 10/2020
Journal Article
American journal of respiratory and critical care medicine, ISSN 1073-449X, 02/2017, Volume 195, Issue 3, pp. 302 - 313
Gastroesophageal reflux | Exacerbation-prone asthma | Bronchodilator reversibility | Sinusitis | Eosinophils | Respiratory System | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Science & Technology | Bronchodilator Agents - therapeutic use | Bronchodilator Agents - administration & dosage | Eosinophils - drug effects | Humans | Middle Aged | Male | Nitric Oxide - analysis | Immunoglobulin E - blood | Albuterol - administration & dosage | Asthma - immunology | Adult | Female | Child | Asthma - epidemiology | Body Mass Index | Severity of Illness Index | Disease Susceptibility | Asthma - physiopathology | Comorbidity | Biomarkers - analysis | Breath Tests | Chi-Square Distribution | Asthma - drug therapy | Inflammation - etiology | Disease Progression | Sputum - chemistry | Drug Resistance - immunology | Adolescent | Sex Distribution | Albuterol - therapeutic use | Index Medicus | Abridged Index Medicus | sinusitis | eosinophils | bronchodilator reversibility | gastroesophageal reflux | Original | exacerbation-prone asthma
Journal Article